The Indian subsidiary of Germany’s Messe München GmbH, has acquired PharmaTech Expo, a pharmaceutical manufacturing trade fair with over 750 exhibitors, from PharmaTechnologyindex.com Pvt. Ltd., a division of Ahmedabad-based KNS Group. The company announced the acquisition on October 21. Financial terms were not disclosed.
Spread over 30,000 sq. m., the exhibition focuses on pharmaceutical manufacturing, production systems and plant infrastructure. It attracts more than 30,000 visitors, mainly from western and northern India, and showcases machinery, cleanroom technologies, utilities, packaging systems and laboratory solutions.
With the acquisition, Messe Muenchen India’s pharmaceutical and laboratory offering will comprise three shows: analytica Lab India, PharmaCore India and PharmaTech Expo. The company said together they span the value chain, from laboratory research, analytical testing and diagnostics to APIs, formulations, contract manufacturing, production technologies, plant engineering and packaging.
“This acquisition marks a significant step in strengthening our position as a strategic partner to India’s pharmaceutical and laboratory industries,” said Bhupinder Singh, President (IMEA), Messe München, and CEO, Messe Muenchen India.
Messe München Group CEOs Reinhard Pfeiffer and Stefan Rummel said the deal “fits perfectly into the analytica cluster” and underlined the group’s long-term commitment to India. They described the country as an important pillar of the global pharmaceutical industry, citing its manufacturing capabilities, growing research landscape and resilient supply chains.
Aarjav Shah and Ramesh Shah, Directors of PharmaTechnologyindex.com, said the move would combine their industry connections with the German group’s global capabilities and market reach.
Each exhibition will retain its distinct identity and market focus, the company said. PharmaTech Expo will go ahead as scheduled in Chandigarh from April 8 to 10, 2027, and at the Helipad Exhibition Centre, Gandhinagar, from August 5 to 7, 2027.
